30 March 2007
Gender-specific comparison of five QT correction formulae in middle-aged participants in an atherosclerosis prevention program
Bernhard Strohmer, Christiana Christiana Schernthaner, Bernhard Paulweber, Maximilian PichlerMed Sci Monit 2007; 13(4): CR165-171 :: ID: 481097
Abstract
Background: Analysis of QT duration limited to a single heart rate correction formula might be problematic in cross-sectional studies. The aim of this study was to investigate five frequently used equations with respect to over- and under-correction of QT intervals in a middle-aged population without manifest atherosclerotic disease.
Material and Methods: A total of 1199 individuals (851 males, 348 females, aged 39 to 66 years) of the SAPHIR study (Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk) were investigated. Heart rate, RR, and QT intervals were measured automatically from resting ECGs with the 12SL™ ECG Analysis Program (GE Medical Systems). Five methods (Bazett, Fridericia, Framingham, Hodges, and Rautaharju) were used to correct the QT interval for heart rate.
Results: Females had shorter RR intervals than males (963±141 vs. 1022±158 ms, <i>p</i><0.0005), with longer QT (410±28 vs. 404±28 ms, <i>p</i>=0.003) and QTc intervals using all five formulae (<i>p</i><0.0005). No significant differences were observed between the gender groups for the QTc/RR slopes regardless of the formula. The Bazett formula performed the worst and the Fridericia the best in terms of rate adjustment success (slope B=–0.001). The optimal alpha of the best-fit equation (QTc=QT/RR<sup>α</sup>) was calculated as 0.326 for males and 0.328 for females.
Conclusions: These results demonstrate that automatic QT measurements can be used reliably in cardiovascular prevention programs, encouraging further investigation of their clinical value in risk stratification. From an epidemiological perspective, however, the selected QT correction formula applied to a specific population has to be evaluated for appropriateness.
Keywords: Austria, Atherosclerosis - prevention & control, Electrocardiography - methods, Heart Rate - physiology, Regression Analysis, Sex Factors
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952